333 related articles for article (PubMed ID: 24339395)
1. Effect of methotrexate, anti-tumor necrosis factor α, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysis.
Hua C; Barnetche T; Combe B; Morel J
Arthritis Care Res (Hoboken); 2014 Jul; 66(7):1016-26. PubMed ID: 24339395
[TBL] [Abstract][Full Text] [Related]
2. A Systematic Review and Metaanalysis of Antirheumatic Drugs and Vaccine Immunogenicity in Rheumatoid Arthritis.
Subesinghe S; Bechman K; Rutherford AI; Goldblatt D; Galloway JB
J Rheumatol; 2018 Jun; 45(6):733-744. PubMed ID: 29545454
[TBL] [Abstract][Full Text] [Related]
3. Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors.
Kapetanovic MC; Roseman C; Jönsson G; Truedsson L; Saxne T; Geborek P
Arthritis Rheum; 2011 Dec; 63(12):3723-32. PubMed ID: 21834061
[TBL] [Abstract][Full Text] [Related]
4. Vaccination response to protein and carbohydrate antigens in patients with rheumatoid arthritis after rituximab treatment.
Rehnberg M; Brisslert M; Amu S; Zendjanchi K; Håwi G; Bokarewa MI
Arthritis Res Ther; 2010; 12(3):R111. PubMed ID: 20529331
[TBL] [Abstract][Full Text] [Related]
5. Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab.
van Assen S; Holvast A; Benne CA; Posthumus MD; van Leeuwen MA; Voskuyl AE; Blom M; Risselada AP; de Haan A; Westra J; Kallenberg CG; Bijl M
Arthritis Rheum; 2010 Jan; 62(1):75-81. PubMed ID: 20039396
[TBL] [Abstract][Full Text] [Related]
6. Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis.
Crnkic Kapetanovic M; Saxne T; Jönsson G; Truedsson L; Geborek P
Arthritis Res Ther; 2013 Oct; 15(5):R171. PubMed ID: 24286269
[TBL] [Abstract][Full Text] [Related]
7. Vaccine responses in patients with rheumatoid arthritis treated with certolizumab pegol: results from a single-blind randomized phase IV trial.
Kivitz AJ; Schechtman J; Texter M; Fichtner A; de Longueville M; Chartash EK
J Rheumatol; 2014 Apr; 41(4):648-57. PubMed ID: 24584918
[TBL] [Abstract][Full Text] [Related]
8. Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients.
Migita K; Akeda Y; Akazawa M; Tohma S; Hirano F; Ideguchi H; Kozuru H; Jiuchi Y; Matsumura R; Suematsu E; Miyamura T; Mori S; Fukui T; Izumi Y; Iwanaga N; Tsutani H; Saisyo K; Yamanaka T; Ohshima S; Mori N; Matsumori A; Takahi K; Yoshizawa S; Kawabe Y; Suenaga Y; Ozawa T; Hamada N; Komiya Y; Matsui T; Furukawa H; Oishi K
Arthritis Res Ther; 2015 Dec; 17():357. PubMed ID: 26653668
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine.
Kapetanovic MC; Nagel J; Nordström I; Saxne T; Geborek P; Rudin A
Vaccine; 2017 Feb; 35(6):903-908. PubMed ID: 28081972
[TBL] [Abstract][Full Text] [Related]
10. Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients.
Kapetanovic MC; Saxne T; Nilsson JA; Geborek P
Rheumatology (Oxford); 2007 Apr; 46(4):608-11. PubMed ID: 17114801
[TBL] [Abstract][Full Text] [Related]
11. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.
Kapetanovic MC; Saxne T; Sjöholm A; Truedsson L; Jönsson G; Geborek P
Rheumatology (Oxford); 2006 Jan; 45(1):106-11. PubMed ID: 16287919
[TBL] [Abstract][Full Text] [Related]
12. Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients.
Westra J; van Assen S; Wilting KR; Land J; Horst G; de Haan A; Bijl M
Clin Exp Immunol; 2014 Oct; 178(1):40-7. PubMed ID: 24889761
[TBL] [Abstract][Full Text] [Related]
13. Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial.
Bingham CO; Looney RJ; Deodhar A; Halsey N; Greenwald M; Codding C; Trzaskoma B; Martin F; Agarwal S; Kelman A
Arthritis Rheum; 2010 Jan; 62(1):64-74. PubMed ID: 20039397
[TBL] [Abstract][Full Text] [Related]
14. Immune response to influenza vaccine and pneumococcal polysaccharide vaccine under IL-6 signal inhibition therapy with tocilizumab.
Tsuru T; Terao K; Murakami M; Matsutani T; Suzaki M; Amamoto T; Nakashima H; Akiyama A; Nishimoto N
Mod Rheumatol; 2014 May; 24(3):511-6. PubMed ID: 24252023
[TBL] [Abstract][Full Text] [Related]
15. Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.
Kapetanovic MC; Kristensen LE; Saxne T; Aktas T; Mörner A; Geborek P
Arthritis Res Ther; 2014 Jan; 16(1):R2. PubMed ID: 24383620
[TBL] [Abstract][Full Text] [Related]
16. Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different antirheumatic drugs.
Crnkic Kapetanovic M; Saxne T; Truedsson L; Geborek P
Arthritis Res Ther; 2013 Jan; 15(1):R1. PubMed ID: 23286772
[TBL] [Abstract][Full Text] [Related]
17. Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus.
Migita K; Akeda Y; Akazawa M; Tohma S; Hirano F; Ideguchi H; Matsumura R; Suematsu E; Miyamura T; Mori S; Fukui T; Izumi Y; Iwanaga N; Tsutani H; Saisyo K; Yamanaka T; Ohshima S; Sugiyama T; Kawabe Y; Katayama M; Suenaga Y; Okamoto A; Ohshima H; Okada Y; Ichikawa K; Yoshizawa S; Kawakami K; Matsui T; Furukawa H; Oishi K
Arthritis Res Ther; 2015 Jun; 17(1):149. PubMed ID: 26036592
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the safety of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis: results from a randomized controlled trial.
Greenwald MW; Shergy WJ; Kaine JL; Sweetser MT; Gilder K; Linnik MD
Arthritis Rheum; 2011 Mar; 63(3):622-32. PubMed ID: 21360491
[TBL] [Abstract][Full Text] [Related]
19. Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial.
Park JK; Lee YJ; Shin K; Ha YJ; Lee EY; Song YW; Choi Y; Winthrop KL; Lee EB
Ann Rheum Dis; 2018 Jun; 77(6):898-904. PubMed ID: 29572291
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and impact on disease activity of influenza and pneumococcal vaccines in systemic lupus erythematosus: a systematic literature review and meta-analysis.
Pugès M; Biscay P; Barnetche T; Truchetet MÉ; Richez C; Seneschal J; Gensous N; Lazaro E; Duffau P
Rheumatology (Oxford); 2016 Sep; 55(9):1664-72. PubMed ID: 27160278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]